Anaplastic thyroid cancer is among the most deadly cancers, with historical medial survival of only about 3 months after diagnosis. Being a very rare cancer, it is also very challenging to obtain competitive federal grants to study this cancer. We have recently made great progress in improving survival and quality of life for patients with anaplastic thyroid cancer. As Gateway for Cancer research has a particular mission to fund clinical trials for patients with rare and aggressive cancers, we are seeking collaboration with Gateway for Cancer Research in fundraising for anaplastic thyroid cancer clinical trials. We thank you for your generous support of Gateway's mission to fund cutting-edge and patient-centric research in order to drive transformational advances and treatment breakthroughs for patients with anaplastic thyroid cancer.
Gateway for Cancer Research
If you would like to make a check please send to: Gateway for Cancer Research, 500 Remington Road, Suite 200, Schaumburg, IL 60173